BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CYP51
,
nitric oxide metabolic process
,
Arthritis
,
Endothelial cell
,
Alcohol
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rhag
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal liver
Superior cervical ganglion
Bone marrow
Ciliary ganglion
Macrophage of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Esterification of Ginsenoside Rh2 Enhanced Its Cellular Uptake and Antitumor Activity in Human HepG2…
Production of bioactive ginsenosides Rh2 and Rg3 by metabolically engineered yeasts.
Comparative analysis of the expression level of recombinant ginsenoside-transforming β-glucosidase i…
In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: i…
Induction of apoptosis and reversal of permeability glycoprotein-mediated multidrug resistance of MC…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for rhag
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ